Active	Status	Sponsor type	Region	Phase	Filter
15 Active 16 Inactive 31 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Simon, Patsy
NCT04601532: Superficial Partial-Thickness Burn Study	Terminated	4	26	US	Catasyn™ Advanced Technology Hydrogel and SynePure™ Wound Cleanser, Silver Sulfadiazine, Silvadene Topical Product	J. Peter Rubin, MD, Synedgen, Inc., United States Department of Defense	Superficial Partial Thickness Burn	12/22	12/22
NCT05343143: NeuraGen 3D Pilot Study	Terminated	N/A	1	US	NeuraGen 3D Nerve Guide Matrix	Integra LifeSciences Corporation	Digital Nerve Injury	07/23	05/24
Rubin, J Peter
NCT04601532: Superficial Partial-Thickness Burn Study	Terminated	4	26	US	Catasyn™ Advanced Technology Hydrogel and SynePure™ Wound Cleanser, Silver Sulfadiazine, Silvadene Topical Product	J. Peter Rubin, MD, Synedgen, Inc., United States Department of Defense	Superficial Partial Thickness Burn	12/22	12/22
NCT04440189: Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis	Recruiting	N/A	124	US	GID SVF-2 Device System	GID BIO, Inc.	Osteoarthritis, Knee	12/23	12/24
Shirley, Eleanor
NCT04601532: Superficial Partial-Thickness Burn Study	Terminated	4	26	US	Catasyn™ Advanced Technology Hydrogel and SynePure™ Wound Cleanser, Silver Sulfadiazine, Silvadene Topical Product	J. Peter Rubin, MD, Synedgen, Inc., United States Department of Defense	Superficial Partial Thickness Burn	12/22	12/22
NCT04440189: Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis	Recruiting	N/A	124	US	GID SVF-2 Device System	GID BIO, Inc.	Osteoarthritis, Knee	12/23	12/24